Commentary: Insulin-Producing Organoids Engineered From Islet and Amniotic Epithelial Cells to Treat Diabetes

Cobianchi, Lorenzo; Moeckli, Beat; Croce, Stefania

doi:10.3389/fendo.2020.546114

Scientific article

Comment

English

Commentary: Insulin-Producing Organoids Engineered From Islet and Amniotic Epithelial Cells to Treat Diabetes

ContributorsCobianchi, Lorenzo; Moeckli, Beat

; Croce, Stefania

Published inFrontiers in endocrinology, vol. 11, 546114

Publication date2020-10-06

First online date2020-10-06

Abstract

A Commentary on : "Insulin-Producing Organoids Engineered from Islet and Amniotic Epithelial Cells to Treat Diabetes" By Lebreton F, Lavallard V, Bellofatto K, Bonnet R, Wassmer CH, Perez L, Kalandadze V, Follenzi A, Boulvain M, Kerr-Conte J, Goodman DJ, Bosco D, Berney T, Berishvili E. Nat Commun. (2019). 10(1):4491. doi: 10.1038/s41467-019-12472-3.

Keywords

Diabetes
Organ replacement
Organoids
Stem cells
Surgery

NoteThe commented article is also available in Archive ouverte UNIGE: https://archive-ouverte.unige.ch/unige:134290

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Transplantation et hépatologie (905)

Citation (ISO format)

COBIANCHI, Lorenzo, MOECKLI, Beat, CROCE, Stefania. Commentary: Insulin-Producing Organoids Engineered From Islet and Amniotic Epithelial Cells to Treat Diabetes. In: Frontiers in endocrinology, 2020, vol. 11, p. 546114. doi: 10.3389/fendo.2020.546114